EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieKlinische Studie (Phase III)

Randomised controlled trial of adjunctive triamcinolone acetonide in eyes undergoing vitreoretinal surgery following open globe trauma: The ASCOT study

Edward J Casswell iD, Suzie Cro iD, Victoria R Cornelius, Philip J Banerjee, Tapiwa M Zvobgo, Rhiannon Tudor Edwards, Victory Ezeofor, Bethany Anthony, Syed Mohammed Shahid iD, Catey Bunce iD, Joanna Kelly, Caroline Murphy und 3 weitere

British Journal of Ophthalmology · 2024

DOI: 10.1136/bjo-2022-322787 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift British Journal of Ophthalmology, 2024. Verfasst von Edward J Casswell und 14 weiteren Autor:innen. Beteiligte Einrichtung: Sussex Eye Hospital, Brighton, UK edcasswell@hotmail.com. Hauptthemen laut MEDLINE: Vitreoretinal Surgery, Eye Injuries, Retinal Detachment, Diabetic Retinopathy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: National Institute for Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/aims To investigate the clinical effectiveness of adjunctive triamcinolone acetonide (TA) given at the time of vitreoretinal surgery following open globe trauma (OGT).

Methods

A phase 3, multicentre, double-masked randomised controlled trial of patients undergoing vitrectomy following OGT comparing adjunctive TA (intravitreal and subtenons) against standard care (2014–2020). The primary outcome was the proportion of patients with at least 10 Early Treatment Diabetic Retinopathy Study (ETDRS) letter improvement in corrected visual acuity (VA) at 6 months. Secondary outcomes included: change in ETDRS, retinal detachment (RD) secondary to PVR, retinal reattachment, macular reattachment, tractional RD, number of operations, hypotony, elevated intraocular pressure and quality of life.

Results

280 patients were randomised over 75 months, of which 259 completed the study. 46.9% (n=61/130) of patients in the treatment group had a 10-letter improvement in VA compared with 43.4% (n=56/129) of the control group (difference 3.5% (95% CI −8.6% to 15.6%), OR=1.03 (95% CI 0.61 to 1.75), p=0.908)). Secondary outcome measures also failed to show any treatment benefit. For two of the secondary outcome measures, stable complete retinal and macular reattachment, outcomes were worse in the treatment group compared with controls, respectively, 51.6% (n=65/126) vs 64.2% (n=79/123), OR=0.59 (95% CI 0.36 to 0.99), and 54.0% (n=68/126) vs 66.7% (n=82/123), OR=0.59 (95% CI 0.35 to 0.98), for TA vs control.

Conclusion

The use of combined intraocular and sub-Tenons capsule TA is not recommended as an adjunct to vitrectomy surgery following OGT. Trial registration number NCT02873026 .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vitreoretinal SurgeryEye InjuriesRetinal DetachmentDiabetic RetinopathyHumansTriamcinolone AcetonideGlucocorticoidsQuality of LifeVitrectomyTreatment Outcome

Stichwörter der Autor:innen

RetinaTraumaVitreous

Substanzen

Triamcinolone AcetonideGlucocorticoids

Autor:innen und Institutionen

  • Sussex Eye Hospital, Brighton, UK edcasswell@hotmail.com.
  • Ophthalmology, University Hospitals Sussex NHS Foundation Trust, Worthing, UK.
  • Vitreoretinal Department, Moorfields Eye Hospital, London, UK.
  • Imperial Clinical Trials Unit, Imperial College London, London, UK.
  • Ophthalmology, Frimley Health NHS Foundation Trust, Frimley, UK.
  • NIHR Moorfields Biomedical Research Centre, London, UK.

ORCID-Profile: Edward J Casswell, Suzie Cro, Syed Mohammed Shahid, Catey Bunce

Förderung

  • National Institute for Health Research

Zitieren

APA

Casswell, E. J., Cro, S., Cornelius, V. R., Banerjee, P. J., Zvobgo, T. M., Tudor Edwards, R., Ezeofor, V., Anthony, B., Shahid, S. M., Bunce, C., Kelly, J., Murphy, C., Robertson, E., Charteris, D., & ASCOT Investigator Study Group (2024). Randomised controlled trial of adjunctive triamcinolone acetonide in eyes undergoing vitreoretinal surgery following open globe trauma: The ASCOT study. British Journal of Ophthalmology. https://doi.org/10.1136/bjo-2022-322787

Vancouver

Casswell EJ, Cro S, Cornelius VR, Banerjee PJ, Zvobgo TM, Tudor Edwards R, et al. Randomised controlled trial of adjunctive triamcinolone acetonide in eyes undergoing vitreoretinal surgery following open globe trauma: The ASCOT study. British Journal of Ophthalmology. 2024. doi:10.1136/bjo-2022-322787

BibTeX
@article{Casswell2024,
  author = {Casswell, Edward J and Cro, Suzie and Cornelius, Victoria R and Banerjee, Philip J and Zvobgo, Tapiwa M and Tudor Edwards, Rhiannon and Ezeofor, Victory and Anthony, Bethany and Shahid, Syed Mohammed and Bunce, Catey and Kelly, Joanna and Murphy, Caroline and Robertson, Elizabeth and Charteris, David and ASCOT Investigator Study Group, ASCOT Investigator Study Group},
  title = {Randomised controlled trial of adjunctive triamcinolone acetonide in eyes undergoing vitreoretinal surgery following open globe trauma: The ASCOT study},
  journal = {British Journal of Ophthalmology},
  year = {2024},
  doi = {10.1136/bjo-2022-322787}
}
Kostenlos starten →